Claret Asset Management Corp
Position in BHC — Bausch Health Companies Inc.
CIK 1735513
MONTREAL, A8
Position in BHC
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$1,006,252
+$494,397 QoQ
Shares Held
204,108
+1010.6% QoQ
Ownership
0.055%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
#62
of 220 holders
Holding Since
Mar 2020
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BHC Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Claret Asset Management Corp holds $30,317,140 across 7 Drug Manufacturers - Specialty & Generic names. BHC ranks #2 (3.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INDV |
Indivior Pharmaceuticals, Inc.
|
685,523 | $28,127,008 | |
| 2 | BHC |
Bausch Health Companies Inc.
This page
|
204,108 | $1,006,252 | |
| 3 | ZTS |
Zoetis Inc.
|
3,526 | $253,378 | |
| 4 | VTRS |
Viatris Inc
|
15,214 | $241,598 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
1,425 | $240,169 | |
| 6 | ELAN |
Elanco Animal Health Inc
|
9,119 | $224,418 | |
| 7 | UTHR |
UNITED THERAPEUTICS Corp
|
414 | $224,317 |
All Filings in BHC
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,006,252 | 204,108 | Shares | Sole | 2026-07-27 | |
| 2021-09-30 | $511,855 | 18,379 | Shares | Sole | 2021-12-02 | |
| 2021-06-30 | $545,938 | 18,620 | Shares | Sole | 2021-08-09 | |
| 2021-03-31 | $661,556 | 20,843 | Shares | Sole | 2021-05-04 | |
| 2020-12-31 | $399,984 | 19,230 | Shares | Sole | 2021-02-02 | |
| 2020-09-30 | $304,413 | 19,589 | Shares | Sole | 2020-10-29 | |
| 2020-06-30 | $351,789 | 19,234 | Shares | Sole | 2020-08-06 | |
| 2020-03-31 | $254,401 | 16,413 | Shares | Sole | 2020-04-06 | |
| No filing history on record for this holder in this stock. | ||||||